Emcure in News

For Media Queries, write to: naveen.soni@emcure.com (Corporate Communications)

Emcure Pharmaceuticals to Acquire Remaining Stake in its Subsidiary, Zuventus Healthcare Ltd.

Emcure Pharmaceuticals Achieves Robust Q4FY25 Performance with 19% Revenue Growth and 63% Profit After Tax Growth

Emcure Joins the 2025 Ice Bucket Challenge Revival, but with a Twist around Mother’s Day

Emcure’s European subsidiary Tillomed acquires strategic pharma portfolio from Manx

Emcure Expands OTC Portfolio with Arth Supplements, Welcomes Vidya Balan as Brand Ambassador

Emcure Pharma Announces Strong Q3FY25 with 18% Revenue Growth and 30% Profit After Tax Growth’

Cricket Icon MS Dhoni and Emcure’s Namita Thapar Unite to Champion Women’s Health Awareness

Emcure Pharmaceuticals Inaugurates World-class R&D centre

Emcure and MS Dhoni Drive Indias Fight Against Anemia with New National Campaign on International Mens Day

Emcure Pharmas SAKHI – Diabetes Awareness Program makes it to Asia Book of Records

Load More
Satish Mehta
Managing Director & CEO
Samit Mehta
Whole-time Director
Namita Thapar
Whole-time Director
Vikas Thapar
President, Corporate Development & Strategy
Rajesh Nair
President, HR
Sanand
Hinjawadi Emcure Building
Emcure Hinjawadi Building
API Kurkumbh Building
Emcure Logo (AI Format)
Emcure Logo (JPG Format)
Emcure Logo (PNG Format)
Emcure Logo (PDF format)

Recent Coverage

UPDATE

Emcure stake buy: Pharma firm to acquire 20.42% in Zuventus for Rs 724.9 crore; full ownership to aid consolidation

  • Jun 24, 2025
  • Online

UPDATE

Emcure Pharmaceuticals to expand gynaecology, derma portfolio for India market in FY26

  • May 22, 2025
  • Online, Print

UPDATE

Emcure Pharmaceuticals Q4 Results: Profit surges 63% YoY on strong domestic and international growth

  • May 22, 2025
  • Online, Print